Challenging the “Good Cancer” Myth: What Patients and Clinicians Need to Know

Dr. Lori Wirth, MD—Elizabeth and Michael Ruane Chair of Endocrine Oncology; Medical Director of the Massachusetts General Hospital Center for Head and Neck Cancers; and Professor of Medicine at Harvard Medical School—joins MedInsights Unleashed to discuss modern thyroid cancer care. She explores differentiated, medullary, and anaplastic disease; advances in diagnosis and treatment; the role of genomic testing, including BRAF V600E and RET; and the use of active surveillance for selected patients. Dr. Wirth underscores the importance of individualized care and shared decision-making, offering clear, practical insights for patients, caregivers, and clinicians navigating an evolving thyroid cancer landscape.